Wells Fargo’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$128K Sell
13,972
-8,944
-39% -$126K ﹤0.01% 4963
2025
Q4
$367K Buy
22,916
+12,468
+119% +$363K ﹤0.01% 4698
2025
Q3
$487K Buy
10,448
+1,122
+12% +$41.3K ﹤0.01% 4325
2025
Q2
$273K Buy
9,326
+1,657
+22% +$45.1K ﹤0.01% 4573
2025
Q1
$197K Buy
7,669
+165
+2% +$4.06K ﹤0.01% 4714
2024
Q4
$217K Buy
7,504
+1,608
+27% +$49K ﹤0.01% 4753
2024
Q3
$140K Buy
5,896
+247
+4% +$5.48K ﹤0.01% 4817
2024
Q2
$97.7K Buy
5,649
+4,290
+316% +$74.9K ﹤0.01% 4954
2024
Q1
$30.3K Buy
1,359
+54
+4% +$1.12K ﹤0.01% 5447
2023
Q4
$23.9K Buy
1,305
+244
+23% +$4.03K ﹤0.01% 5569
2023
Q3
$18.4K Sell
1,061
-916
-46% -$15.9K ﹤0.01% 5633
2023
Q2
$36K Buy
1,977
+1,498
+313% +$29.9K ﹤0.01% 5557
2023
Q1
$8.22K Hold
479
﹤0.01% 5923
2022
Q4
$11.1K Sell
479
-28
-6% -$649 ﹤0.01% 5505
2022
Q3
$12K Buy
507
+12
+2% +$286 ﹤0.01% 5625
2022
Q2
$9K Sell
495
-962
-66% -$21.4K ﹤0.01% 5813
2022
Q1
$52K Sell
1,457
-388
-21% -$24.3K ﹤0.01% 5642
2021
Q4
$160K Buy
1,845
+1,423
+337% +$118K ﹤0.01% 5389
2021
Q3
$48K Buy
+422
New +$62.5K ﹤0.01% 5643

Other funds holding LENZ